Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 11
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data | Jordan A, Chen D, Yi QL, Kanias T, Gladwin MT, Acker JP | 2016 | Vox Sang | View Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data | Researchers | Basic research |
Donor motivation in Xi'an, China: comparison with Canadian donors | O'Brien SF, Shao ZJ, Osmond L, Yi QL, Li CY, An QX | 2012 | Vox Sang | View Donor motivation in Xi'an, China: comparison with Canadian donors | Blood operators | Other |
Measures to prevent transfusion-related acute lung injury (TRALI) | Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sanchez-Guerrero SA, Baptista-Gonzalez HA, Martinez-Murillo C, Guerra-Marquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muniz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S | 2012 | Vox Sang | View Measures to prevent transfusion-related acute lung injury (TRALI) | Blood operators | Benchmarking and standard setting |
Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20–24°C for up to 24 h | Sheffield WP, Bhakta V, Jenkins C | 2016 | Vox Sang | View Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20–24°C for up to 24 h | Blood operators | New or improved product or process |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Cardigan R, New HV, Estcourt L, Zhiburt E, Dubey R, Bengtsson J, Jöud M, Castillo C, Cid J, Lozano M, Gounder D, Flanagan P, Morley S, Clarke G, Devine D, Hindawi S, AlOtaibi A, Bub CB, Kutner JM, Ikeda T, Goto N, Okazaki H, Fontaine MJ, Pasion J, Song L, Latham T, Kerkhoffs JL, de Haas M, Zwaginga JJ, Gathof BS, Ommer K, Pirenne F, Raba M, Francois A, Daly J, Powley T, Dunbar N | 2022 | Vox Sang | View International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Health care providers | Benchmarking and standard setting |
Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis | Szkotak AJ, Lunty B, Nahirniak S, Clarke G | 2016 | Vox Sang | View Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis | Health care providers | Clinical research |
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections | Sharma RR, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung JNS, Tsoi WC, Marwaha N, Sachdev S, Tadokoro K, Tani Y, Matsukura H, Gbuz So O, Shantseva N, Zhiburt E, Hindawi S, Chay J, Huang T, Teo D, Moleli N, Oyonarte S, Jayasekara SBA, Bokhorst A, van den Burg P, Hewitt P, Bianco C, Kessler D | 2017 | Vox Sang | View Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections | Researchers | Clinical research |
Vox Sanguinis International Forum on Donor Incentives | Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz E-M, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A | 2020 | Vox Sang | View Vox Sanguinis International Forum on Donor Incentives | Blood operators | Benchmarking and standard setting |
Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, Goldman M, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Researchers | Benchmarking and standard setting |
Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Bicalho B, Pereira AS, Acker JP | 2015 | Vox Sang | View Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Researchers | Basic research |
Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm?derived Staphylococcus epidermidis in buffy coat platelet concentrates | Taha M, Culibrk B, Kalab M, Schubert P, Yi QL, Goodrich R, Ramirez?Arcos S | 2017 | Vox Sang | View Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm?derived Staphylococcus epidermidis in buffy coat platelet concentrates | Researchers | New or improved product or process |
Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Wu HX, Robitaille A, Cserti-Gazdewich C, Callum J | 2021 | Vox Sang | View Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Health care providers | Clinical research |
PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates | Greco CA, Maurer-Spurej E, Scott MD, Kalab M, Nakane N, Ramirez-Arcos SM | 2011 | Vox Sang | View PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates | Researchers | Basic research |
Biofilm-associated accumulation-associated protein (Aap): A contributing factor to the predominant growth of Staphylococcus epidermidis in platelet concentrates | Alabdullatif M, Ramirez-Arcos S | 2019 | Vox Sang | View Biofilm-associated accumulation-associated protein (Aap): A contributing factor to the predominant growth of Staphylococcus epidermidis in platelet concentrates | Researchers | New or improved product or process |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
A Comparative Study of McFarland Turbidity Standards and the Densimat Photometer to Determine Bacterial Cell Density | Zapata A, Ramirez-Arcos S | 2015 | Curr Microbiol | View A Comparative Study of McFarland Turbidity Standards and the Densimat Photometer to Determine Bacterial Cell Density | Blood operators | New or improved product or process |
A randomized controlled trial comparing the outcome of critically ill adults who received fresher vs. older red cells units | Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Walsh T, Stanworth S, Campbell H, Boyd J, Burrows H, Hemmatapour S, on behalf of the Canadian Critical Care Trials Group | 2016 | ISBT Sci Ser | View A randomized controlled trial comparing the outcome of critically ill adults who received fresher vs. older red cells units | Health care providers | Clinical research |
Drug-induced immune haemolytic anaemias | Branch DR | 2019 | ISBT Sci Ser | View Drug-induced immune haemolytic anaemias | Researchers | Basic research |
A fresh look at measuring quality in blood components | Devine DV, Chen D | 2014 | ISBT Sci Ser | View A fresh look at measuring quality in blood components | Blood operators | Other |
Iron depletion and routine ferritin measurement in blood donors | Goldman M | 2015 | ISBT Sci Ser | View Iron depletion and routine ferritin measurement in blood donors | Blood operators | New or improved product or process |
Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Kipkeu BJ, Almizraq R, Branch DR, Acker JP, Holovati JL | 2018 | ISBT Sci Ser | View Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Researchers | Basic research |
A role for red cell clearance in antibody-mediated inhibition of erythrocyte alloimmunization? | Marjoram D, Cruz-Leal Y, Bernardo L, Lazarus AH | 2017 | ISBT Sci Ser | View A role for red cell clearance in antibody-mediated inhibition of erythrocyte alloimmunization? | Researchers | Basic research |
Our older population: donors as well as recipients? | Goldman M, O'Brien S | 2017 | ISBT Sci Ser | View Our older population: donors as well as recipients? | Health care providers | Clinical research |
Platelet immunobiology: platelets as prey and predator | Kapur R, Semple JW | 2018 | ISBT Sci Ser | View Platelet immunobiology: platelets as prey and predator | Researchers | Basic research |
Megakaryopoiesis and ex vivo differentiation of stem cells into megakaryocytes and platelets | Pineault N, Boisjoli GJ | 2015 | ISBT Sci Ser | View Megakaryopoiesis and ex vivo differentiation of stem cells into megakaryocytes and platelets | Researchers | Basic research |
Introducing the red cell storage lesion | Chen D, Serrano K, Devine DV | 2016 | ISBT Sci Ser | View Introducing the red cell storage lesion | Blood operators | Basic research |
Understanding iron depletion and overload in blood donors | O'Brien SF, Goldman M | 2017 | ISBT Sci Ser | View Understanding iron depletion and overload in blood donors | Blood operators | Clinical research |
Mitochondrial damage-associated molecular patterns in blood transfusion products | Marcoux G, Boilard E | 2017 | ISBT Sci Ser | View Mitochondrial damage-associated molecular patterns in blood transfusion products | Researchers | Basic research |
The cellular pathophysiology of immune thrombocytopenia | Semple JW | 2013 | ISBT Sci Ser | View The cellular pathophysiology of immune thrombocytopenia | Researchers | Basic research |
Dengue virus replication by platelets | Pryzdial ELG, Sutherland MR, Simon AY | 2017 | ISBT Sci Ser | View Dengue virus replication by platelets | Researchers | Basic research |
How to get a paper published | Walsh GM, Devine DV | 2014 | ISBT Sci Ser | View How to get a paper published | Other | Other |
Public Perceptions of Pathogen Reduction Technology in the Canadian Donor Blood Supply | Gray N, Newbold KB, Lane SJ, Heddle NM, Webert K, Eyles J | 2015 | ISBT Sci Ser | View Public Perceptions of Pathogen Reduction Technology in the Canadian Donor Blood Supply | Blood operators | Other |
Survey for bacterial testing of platelet components in Latin America | Ramirez-Arcos S, McDonald CP, Benjamin RJ, for the ISBT Working Party Transfusion Transmitted Infectious Diseases Bacterial Subgroup | 2017 | ISBT Sci Ser | View Survey for bacterial testing of platelet components in Latin America | Blood operators | New or improved product or process |
Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Goldman M, Yi Q-L, O'Brien SF | 2018 | ISBT Sci Ser | View Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Blood operators | New or improved product or process |
Blood collection | Armstrong B, Reviewer for Second Edition: Goldman M | 2020 | ISBT Sci Ser | View Blood collection | Health care providers | Benchmarking and standard setting |
Assessing the efficacy of a single-unit red blood cell transfusion policy at a multisite transfusion service using a computerized retrospective audit | Covello TPC, Quinn JG, Kumar-Misir A, Watson S, Almohammadi M, Crocker BD, Conrad DM, Tennankore K, Sadek I, Kahwash E, Cheng CK | 2016 | ISBT Sci Ser | View Assessing the efficacy of a single-unit red blood cell transfusion policy at a multisite transfusion service using a computerized retrospective audit | Blood operators | Clinical research |
The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Lagerquist O, Poseluzny D, Werstiuk G, Slomp J, Maier M, Nahirniak S, Clarke G | 2017 | ISBT Sci Ser | View The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Health care providers | Ethical, legal and social implications research |
Blood donors | Armstrong B, Reviewer for Second Edition: Goldman M | 2020 | ISBT Sci Ser | View Blood donors | Health care providers | Benchmarking and standard setting |
Donor selection for recipient safety | Goldman M | 2013 | ISBT Sci Ser | View Donor selection for recipient safety | Health care providers | Clinical research |
Bacterial safety of blood components - a congress review of the ISBT transfusion-transmitted infectious diseases working party, bacterial subgroup | Ramirez-Arcos S, McDonald C, Deol P, Kreuger AL, Patel N, Pidcoke H, Prax M, Seltsam A, Stassinopoulos A, The ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2019 | ISBT Sci Ser | View Bacterial safety of blood components - a congress review of the ISBT transfusion-transmitted infectious diseases working party, bacterial subgroup | Researchers | Other |
A generic modelling framework to evaluate network blood management policies: The Canadian Blood Services experience | Blake JT, Hardy M | 2014 | Oper Res Health Care | View A generic modelling framework to evaluate network blood management policies: The Canadian Blood Services experience | Blood operators | New or improved product or process |
Determining recruiting strategies for an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2016 | Oper Res Health Care | View Determining recruiting strategies for an adult stem cell registry | Blood operators | New or improved product or process |
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Li N, Chiang F, Down DG, Heddle NM | 2021 | Oper Res Health Care | View A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Health care providers | New or improved product or process |
ResearchUnit: How do bacteria behave during platelet production? | Ramirez-Arcos S | 2017 | Blood.ca website | View ResearchUnit: How do bacteria behave during platelet production? | Other | Other |
Circulare d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleuccoyté (PD) | Jenkins C | 2018 | Blood.ca website | View Circulare d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleuccoyté (PD) | Health care providers | Benchmarking and standard setting |
Perforation des sacs de composants sanguins | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Perforation des sacs de composants sanguins | Other | Other |
Système Rhésus : l’anticorps anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-Cw | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Red blood cells, leukocytes reduced (LR) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
L’exploration des frontières de l’hémolyse associée aux IgIV | Pendergrast J, Branch D | 2020 | Blood.ca website | View L’exploration des frontières de l’hémolyse associée aux IgIV | Health care providers | Benchmarking and standard setting |